Overview

A Study of Prevention and Treatment of Postmenopausal Osteoporosis in Chinese Women

Status:
Completed
Trial end date:
2006-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this trial is to study the efficacy and safety of low dose of estradiol valerate in the prevention and treatment of postmenopausal osteoporosis.
Phase:
Phase 4
Details
Lead Sponsor:
Peking Union Medical College
Treatments:
Estradiol
Estradiol 17 beta-cypionate
Estradiol 3-benzoate
Estradiol valerate
Medroxyprogesterone
Medroxyprogesterone Acetate
Polyestradiol phosphate